Itama Ranoraya (IRRA) - Total Assets
Based on the latest financial reports, Itama Ranoraya (IRRA) holds total assets worth Rp2.72 Trillion IDR (≈ $159.47 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See IRRA total equity for net asset value and shareholders' equity analysis.
Itama Ranoraya - Total Assets Trend (2016–2024)
This chart illustrates how Itama Ranoraya's total assets have evolved over time, based on quarterly financial data.
Itama Ranoraya - Asset Composition Analysis
Current Asset Composition (December 2024)
Itama Ranoraya's total assets of Rp2.72 Trillion consist of 49.1% current assets and 50.9% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 1.7% |
| Accounts Receivable | Rp471.44 Billion | 28.4% |
| Inventory | Rp266.65 Billion | 16.1% |
| Property, Plant & Equipment | Rp51.17 Billion | 3.1% |
| Intangible Assets | Rp0.00 | 0.0% |
| Goodwill | Rp0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Itama Ranoraya's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Itama Ranoraya.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Itama Ranoraya's current assets represent 49.1% of total assets in 2024, a decrease from 69.9% in 2016.
- Cash Position: Cash and equivalents constituted 1.7% of total assets in 2024, down from 48.9% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 28.4% of total assets.
Itama Ranoraya Competitors by Total Assets
Key competitors of Itama Ranoraya based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
Itama Ranoraya - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.90 | 1.32 | 1.75 |
| Quick Ratio | 1.09 | 0.99 | 1.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp882.94 Billion | Rp293.55 Billion | Rp219.90 Billion |
Itama Ranoraya - Advanced Valuation Insights
This section examines the relationship between Itama Ranoraya's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.19 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 56.7% |
| Total Assets | Rp1.66 Trillion |
| Market Capitalization | $34.10 Million USD |
Valuation Analysis
Below Book Valuation: The market values Itama Ranoraya's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Itama Ranoraya's assets grew by 56.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Itama Ranoraya (2016–2024)
The table below shows the annual total assets of Itama Ranoraya from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp1.66 Trillion ≈ $97.21 Million |
+56.67% |
| 2023-12-31 | Rp1.06 Trillion ≈ $62.05 Million |
+44.28% |
| 2022-12-31 | Rp733.93 Billion ≈ $43.01 Million |
-6.15% |
| 2021-12-31 | Rp782.04 Billion ≈ $45.82 Million |
+46.10% |
| 2020-12-31 | Rp535.27 Billion ≈ $31.36 Million |
+64.48% |
| 2019-12-31 | Rp325.43 Billion ≈ $19.07 Million |
+138.83% |
| 2018-12-31 | Rp136.26 Billion ≈ $7.98 Million |
+6.73% |
| 2017-12-31 | Rp127.67 Billion ≈ $7.48 Million |
+369.36% |
| 2016-12-31 | Rp27.20 Billion ≈ $1.59 Million |
-- |
About Itama Ranoraya
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more